A randomized, placebo-controlled pilot trial of N-acetylcysteine on oxidative stress and endothelial function in HIV-infected older adults receiving antiretroviral treatment.
aDivision of Infectious Diseases, Indiana University School of Medicine bDepartment of Environmental Health, Indiana University cDepartment of Cellular & Integrative Physiology, Center for Vascular Biology, Indiana University School of Medicine dDepartment of Biostatistics, Indiana University School of Medicine and School of Public Health, Indianapolis, Indiana, USA.
Samir K
SK
Gupta
Lisa M
LM
Kamendulis
Matthias A
MA
Clauss
Ziyue
Z
Liu
D000111:Acetylcysteine / Q000008:administration & dosage / Q000627:therapeutic use*; D000368:Aged; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000502:physiology; D028441:F2-Isoprostanes / Q000097:blood*; D016166:Free Radical Scavengers / Q000008:administration & dosage / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D008315:Malondialdehyde / Q000097:blood; D008875:Middle Aged; D018384:Oxidative Stress / Q000187:drug effects*; D010865:Pilot Projects; D011446:Prospective Studies
D000998:Antiviral Agents; D028441:F2-Isoprostanes; D016166:Free Radical Scavengers; D008315:Malondialdehyde; D000111:Acetylcysteine